Literature DB >> 25058445

Atorvastatin restores arsenic-induced vascular dysfunction in rats: modulation of nitric oxide signaling and inflammatory mediators.

Manickam Kesavan1, Thengumpallil Sasindran Sarath1, Kandasamy Kannan1, Subramaniyam Suresh1, Priyanka Gupta1, Karunakaran Vijayakaran1, Palanisamy Sankar1, Nitin Pandurang Kurade1, Santosh Kumar Mishra1, Souvendra Nath Sarkar2.   

Abstract

We evaluated whether atorvastatin, an extensively prescribed statin for reducing the risks of cardiovascular diseases, can reduce the risk of arsenic-induced vascular dysfunction and inflammation in rats and whether the modulation could be linked to improvement in vascular NO signaling. Rats were exposed to sodium arsenite (100ppm) through drinking water for 90 consecutive days. Atorvastatin (10mg/kg bw, orally) was administered once daily during the last 30days of arsenic exposure. On the 91(st) day, blood was collected for measuring serum C-reactive protein. Thoracic aorta was isolated for assessing reactivity to phenylephrine, sodium nitroprusside and acetylcholine; evaluating eNOS and iNOS mRNA expression and measuring NO production, while abdominal aorta was used for ELISA of cytokines, chemokine and vascular cell adhesion molecules. Histopathology was done in aortic arches. Arsenic did not alter phenylephrine-elicited contraction. Atorvastatin inhibited Emax of phenylephrine, but it augmented the contractile response in aortic rings from arsenic-exposed animals. Sodium nitroprusside-induced relaxation was not altered with any treatment. However, arsenic reduced acetylcholine-induced relaxation and affected aortic eNOS at the levels of mRNA expression, protein concentration, phosphorylation and NO production. Further, it increased aortic iNOS mRNA expression, iNOS-derived NO synthesis, production of pro-inflammatory mediators (IL-1β, IL-6, MCP-1, VCAM, sICAM) and serum C-reactive protein and aortic vasculopathic lesions. Atorvastatin attenuated these arsenic-mediated functional, biochemical and structural alterations. Results show that atorvastatin has the potential to ameliorate arsenic-induced vascular dysfunction and inflammation by restoring endothelial function with improvement in NO signaling and attenuating production of pro-inflammatory mediators and cell adhesion molecules.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Arsenic; Atorvastatin; Inflammatory mediators; Nitric oxide signaling; Rat; Vascular dysfunction

Mesh:

Substances:

Year:  2014        PMID: 25058445     DOI: 10.1016/j.taap.2014.07.008

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  11 in total

1.  The effects of melatonin on liver functions in arsenic-induced liver damage.

Authors:  İlhan Bali; Bülent Bilir; Seyfi Emir; Filiz Turan; Ahsen Yılmaz; Tuba Gökkuş; Murat Aydın
Journal:  Ulus Cerrahi Derg       Date:  2016-10-27

2.  Protective Effects of Baicalin on Arsenic Trioxide-induced Oxidative Damage and Apoptosis in Human Umbilical Vein Endothelial Cells.

Authors:  DA-Tian Bau; Chung-Lin Tsai; Chia-Wen Tsai; Wen-Shin Chang; Jiunn-Cherng Lin; Te-Chun Hsia
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

3.  Unraveling mechanisms of toxicant-induced oxidative stress in cardiovascular disease.

Authors:  Tammy R Dugas
Journal:  Curr Opin Toxicol       Date:  2017-10-12

4.  Low-level arsenic causes chronic inflammation and suppresses expression of phagocytic receptors.

Authors:  Priyanka Prasad; Dona Sinha
Journal:  Environ Sci Pollut Res Int       Date:  2017-03-22       Impact factor: 4.223

5.  Possible vasculoprotective role of linagliptin against sodium arsenite-induced vascular endothelial dysfunction.

Authors:  Uma Jyoti; Sunil Kumar Kansal; Puneet Kumar; Sandeep Goyal
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-02       Impact factor: 3.000

6.  Inorganic arsenic exposure induces sex-disparate effects and exacerbates ischemia-reperfusion injury in the female heart.

Authors:  Ryne Veenema; Kevin M Casin; Prithvi Sinha; Raihan Kabir; Nathan Mackowski; Nicole Taube; Djahida Bedja; Rui Chen; Ana Rule; Mark J Kohr
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-03-01       Impact factor: 4.733

7.  Pharmacological characterization of mechanisms involved in the vasorelaxation produced by rosuvastatin in aortic rings from rats with a cafeteria-style diet.

Authors:  Jorge Skiold López-Canales; Jair Lozano-Cuenca; Oscar Alberto López-Canales; José Carlos Aguilar-Carrasco; Lidia Aranda-Zepeda; Pedro López-Sánchez; Enrique Fernando Castillo-Henkel; Ruth Mery López-Mayorga; Ignacio Valencia-Hernández
Journal:  Clin Exp Pharmacol Physiol       Date:  2015-06       Impact factor: 2.557

Review 8.  Biological effects and epidemiological consequences of arsenic exposure, and reagents that can ameliorate arsenic damage in vivo.

Authors:  Chinthalapally V Rao; Sanya Pal; Altaf Mohammed; Mudassir Farooqui; Mark P Doescher; Adam S Asch; Hiroshi Y Yamada
Journal:  Oncotarget       Date:  2017-05-10

9.  Effect of Telmisartan on Arsenic-Induced (Sub-chronic) Perturbations in Redox Homeostasis, Pro-inflammatory Cascade and Aortic Dysfunction in Wistar Rats.

Authors:  B Rudresh Gowda; N Prakash; C R Santhosh; B H Pavithra; Rashmi Rajashekaraiah; M L Sathyanarayana; Suguna Rao; Prashantkumar Waghe; K R Anjan Kumar; G R Shivaprasad; Y Muralidhar
Journal:  Biol Trace Elem Res       Date:  2021-07-30       Impact factor: 3.738

10.  Kolaviron attenuated arsenic acid induced-cardiorenal dysfunction via regulation of ROS, C-reactive proteins (CRP), cardiac troponin I (CTnI) and BCL2.

Authors:  Ademola Adetokunbo Oyagbemi; Temidayo Olutayo Omobowale; Ebunoluwa Racheal Asenuga; John Olusoji Abiola; Adeolu Alex Adedapo; Momoh Audu Yakubu
Journal:  J Tradit Complement Med       Date:  2017-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.